| Literature DB >> 28625481 |
Kun Qu1, Lisa C Zaba2, Ansuman T Satpathy2, Paul G Giresi3, Rui Li4, Yonghao Jin5, Randall Armstrong6, Chen Jin5, Nathalie Schmitt7, Ziba Rahbar8, Hideki Ueno9, William J Greenleaf10, Youn H Kim11, Howard Y Chang12.
Abstract
Here, we define the landscape and dynamics of active regulatory DNA in cutaneous T cell lymphoma (CTCL) by ATAC-seq. Analysis of 111 human CTCL and control samples revealed extensive chromatin signatures that distinguished leukemic, host, and normal CD4+ T cells. We identify three dominant patterns of transcription factor (TF) activation that drive leukemia regulomes, as well as TF deactivations that alter host T cells in CTCL patients. Clinical response to histone deacetylase inhibitors (HDACi) is strongly associated with a concurrent gain in chromatin accessibility. HDACi causes distinct chromatin responses in leukemic and host CD4+ T cells, reprogramming host T cells toward normalcy. These results provide a foundational framework to study personal regulomes in human cancer and epigenetic therapy.Entities:
Keywords: CTCL; HDAC inhibitor; cancer epigenetics; response predictor
Mesh:
Substances:
Year: 2017 PMID: 28625481 PMCID: PMC5559384 DOI: 10.1016/j.ccell.2017.05.008
Source DB: PubMed Journal: Cancer Cell ISSN: 1535-6108 Impact factor: 31.743